Reducing Discomforts in Critically Ill Patients: the IPREA3 Study

NACompletedINTERVENTIONAL
Enrollment

5,411

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Critical Illness
Interventions
OTHER

Administration of the IPREA3 questionnaire

On the day of the ICU discharge, the bedside nurse administers to the patient the 18-item IPREA questionnaire i.e the nurse asks the patient to rate the severity of each discomfort source contained in the IPREA3 questionnaire experienced during the entire stay in the ICU

OTHER

Immediate feedback through electronic reminder messages

After the nurse had administered the questionnaire, warning messages are displayed on the screen corresponding to the key points to prevent the three discomforts reported with the highest scores

OTHER

Targeted interventions in each ICU to reduce discomforts

"These targeted interventions are implemented through the coordination of two local champions.~The central coordination IPREA3 team sends each month to the local champions monthly and cumulative discomfort scores of their unit (overall score of discomfort and scores for each item) and their ranking relative to other units assigned to the interventional arm i.e applying the IPREA3 program.~The local champions organize monthly meetings with the unit staff to present the results in terms of perceived discomforts measured by the IPREA questionnaire, identify main discomfort sources and actions to be conducted to reduce the discomforts reported with the highest scores in the unit and those that are most easily preventable, and assess the efficacy of already applied measures."

Trial Locations (26)

10000

CH Troyes, Troyes

13003

Hôpital Européen, Marseille

13005

CHU Hôpital Nord, Marseille

17022

CH La Rochelle, La Rochelle

21079

CHU Hôpital Bocage, Dijon

28018

CH Louis Pasteur, Chartres

29609

Hôpital de la Cavale Blanche, Brest

43000

CH Le Puy en Velay, Le Puy-en-Velay

59100

CH Victor Provo, Roubaix

59507

CH Douai, Douai

62300

CH Lens, Lens

67000

CHU NHC, Strasbourg

67100

CHU Hautepierre, Strasbourg

69003

CHU Edouard Herriot, Lyon

75010

CHU Saint Louis APHP, Paris

75013

CHU La Pitié Salpétrière APHP, Paris

75014

CHU Cochin APHP, Paris

Hôpital Saint Joseph, Paris

75015

CHU Hôpital Européen Georges Pompidou APHP, Paris

83100

Hôpital Saint Musse, Toulon

86000

CHU La Milétrie, Poitiers

89000

CH Auxerre, Auxerre

92110

CHU Beaujon APHP, Clichy

92200

Clinique Ambroise Paré, Neuilly-sur-Seine

92380

CHU Raymond Poincaré APHP, Garches

06000

CHU Hôpital Pasteur2, Nice

All Listed Sponsors
lead

Dr Pierre KALFON

OTHER

NCT02442934 - Reducing Discomforts in Critically Ill Patients: the IPREA3 Study | Biotech Hunter | Biotech Hunter